Annvrridhhi Ventures Limited (formerly known as J. Taparia Projects Limited) has successfully regularized the appointment of Ms. Bhavana Hamirbhai Jadav as Non-Executive Independent Director following shareholder approval through postal ballot. The company notified BSE on February 14, 2026, regarding the completion of this corporate governance process.

Shareholder Approval Process

The regularization was achieved through a special resolution passed via postal ballot and remote e-voting. This follows the company's earlier intimation dated January 12, 2026, regarding the postal ballot notice. The approval demonstrates shareholder confidence in the new director's qualifications and potential contribution to the board.

Director Profile and Qualifications

Ms. Jadav brings substantial expertise to the board as a medical doctor with over 25 years of experience in healthcare administration, public service, and holistic wellness. She previously served as In-charge Medical Officer and Insurance Medical Officer under the Department of Health & Family Welfare, Government of Gujarat, where she handled healthcare delivery, insurance governance, compliance, and welfare program implementation.

Professional Background and Expertise

Currently, Ms. Jadav operates as Founder of Manbhav – Holistic Healthcare and Wellness, focusing on multiple areas including:

• Mental health and employee well-being
• Lifestyle coaching and psychotherapy
• Hypnotherapy and yogic healing
• Organizational resilience programs

Her educational qualifications include an M.B.B.S. degree complemented by postgraduate qualifications in Clinical Psychology, Industrial Health, Applied Hypnosis, and Yoga Therapy. This diverse academic background supports her comprehensive approach to healthcare and wellness.

Corporate Governance Compliance

The appointment adheres to SEBI regulations, with the company confirming that Ms. Jadav is not debarred from holding directorial positions by any regulatory authority. Additionally, she maintains no familial relationships with existing directors, ensuring independence in her role.

The regularization process demonstrates Annvrridhhi Ventures' commitment to strengthening its board composition with experienced professionals who can contribute specialized knowledge in healthcare governance, risk management, and policy execution.

Annvrridhhi Ventures Limited has submitted its monitoring agency report for Q3 FY26, confirming no deviation in the utilisation of funds raised through its rights issue for the quarter ended December 31, 2025. The report, prepared by Acuite Ratings & Research Limited and filed with BSE Limited on February 13, 2026, validates the company's adherence to regulatory requirements under SEBI regulations.

Rights Issue Performance and Fund Deployment

The company successfully raised ₹7.40 crores through its rights issue of partly paid-up equity shares, representing 25% of the initial call on the approved issue size of ₹37.80 crores. The monitoring agency report confirms substantial utilisation of the raised capital across designated objects.

Issue Structure and Allotment Details

The rights issue was conducted from November 17, 2025 to December 16, 2025, with allotment completed on December 17, 2025. Out of the approved 3.78 crore shares, 2.96 crore partly paid-up equity shares were allotted at ₹10 per share with ₹2.50 paid on application.

Monitoring Agency Assessment

Acuite Ratings & Research Limited, serving as the appointed monitoring agency, confirmed that all fund utilisation aligns with disclosures in the offer document. The agency verified that no government or statutory approvals were required for the stated objects and found no unfavorable events affecting project viability. The monitoring agency report was prepared based on documents provided by the issuer, bank statements, invoices and statutory auditors certificate issued by M/s. VCA & Associates.

Regulatory Compliance and Corporate Governance

The monitoring report was reviewed by the company's Audit Committee on February 13, 2026, ensuring proper oversight. The report confirms compliance with Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and has been disclosed on the company's website www.annvrridhhi.com .

Annvrridhhi Ventures Limited, formerly J. Taparia Projects Limited, operates under BSE script code 538539 with ISIN INE075K01013. The remaining 75% of the issue amount will be collected through future calls as determined by the Board or Rights Issue Committee, providing flexibility in capital deployment while maintaining regulatory transparency.